TrialThe New England journal of medicine2022
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
Sharon M Castellino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
98 papers cite itlatest 60 shown
this paperpooled ittrialcites it